neo-gambogic acid has been researched along with Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, P; Guo, F; Hu, Y; Ma, L; Ren, Q; Tao, S; Wu, C; Yang, L | 1 |
1 other study(ies) available for neo-gambogic acid and Cirrhosis
| Article | Year |
|---|---|
Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism.
Topics: Animals; Biological Products; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Fibronectins; Fibrosis; Folic Acid; Histones; Kidney; Kidney Diseases; Mice; RNA, Small Interfering; Transforming Growth Factor beta1; Ureteral Obstruction; Xanthenes; Xanthones | 2022 |